Averion Expands Operations to Europe
Averion Expands Operations to Europe and Names John Shillingford, PhD as President of New Wholly-Owned Subsidiary Averion GmbH
May 23, 2006, Framingham, Massachusetts, USA- Averion Inc. announced today its expansion into Europe through the creation of Averion GmbH, a new wholly-owned subsidiary based in Germany. The Company also announced the appointment of John Shillingford, PhD as President of Averion GmbH.
Averion GmbH will work to develop relationships with European clients as well as run European studies for existing North American clients. The new subsidiary will offer Averion?s full range of services including: Auditing, Biometrics, Clinical Monitoring, Clinical Project Management, Compliance and Validation, Database Development, Data Management, Data Monitoring and Clinical Endpoint Committees, Medical Monitoring, Medical Writing, Metrics Consulting, Pharmacovigilance, Program Planning/Study Design and Regulatory Consulting.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025